Author:
Janku Filip,Hong David S.,Fu Siqing,Piha-Paul Sarina A.,Naing Aung,Falchook Gerald S.,Tsimberidou Apostolia M.,Stepanek Vanda M.,Moulder Stacy L.,Lee J. Jack,Luthra Rajyalakshmi,Zinner Ralph G.,Broaddus Russell R.,Wheler Jennifer J.,Kurzrock Razelle
Subject
General Biochemistry, Genetics and Molecular Biology
Reference40 articles.
1. Cancer-specific mutations in PIK3CA are oncogenic in vivo;Bader;Proc. Natl. Acad. Sci. USA,2006
2. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial;Bang;Lancet,2010
3. High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability;Cheung;Cancer Discov,2011
4. Regression models and life-tables;Cox;J. R. Stat. Soc. B,1972
5. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis;De Roock;Lancet Oncol.,2010
Cited by
208 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献